logo
Vaccine Panel Gutted by Kennedy Loses a Member Ahead of First Meeting

Vaccine Panel Gutted by Kennedy Loses a Member Ahead of First Meeting

New York Times6 hours ago

Two weeks ago, Health Secretary Robert F. Kennedy Jr. fired all 17 members of an influential committee that recommends which vaccines Americans should get. He then named eight new members, at least half of whom have expressed some skepticism about vaccines.
By Tuesday night, the panel, the Advisory Committee on Immunization Practices, was down to seven members.
Dr. Michael Ross, a physician licensed in Virginia who is a former professor of obstetrics and gynecology, withdrew from the committee. He was not included in the list of voting members posted on the website of the Centers for Disease Control and Prevention on Tuesday.
The new members were scheduled to meet on Wednesday and Thursday to evaluate data and vote on some new vaccines.
The panel's recommendations carry significant weight. Insurance companies and government programs like Medicaid are required to cover the costs of recommended vaccines, and states often base their mandates for school-aged children on the panel's decisions.
On Monday, Senator Bill Cassidy, Republican of Louisiana, called for delaying the meeting until the committee was 'fully staffed with more robust and balanced representation — as required by law — including those with more direct relevant expertise.'
But the meeting is likely to go ahead as planned. The agenda includes some items associated with the anti-vaccine movement that were settled decades ago.
The panelists are expected to vote on flu vaccines that contain thimerosal, a mercury-based preservative that Mr. Kennedy and others have falsely linked to autism. The presentation before the vote is scheduled to be made not by a C.D.C. staff member, as would be the norm, but by Lyn Redwood, a former leader of Children's Health Defense, an anti-vaccine group Mr. Kennedy founded.
It is unclear why Dr. Ross stepped down from the panel. Andrew Nixon, a spokesman for the Department of Health and Human Services, said on Tuesday afternoon that reports of members withdrawing from the panel were 'untrue' and 'completely false.'
On Tuesday night, Mr. Nixon amended his comments.
'Dr. Michael Ross decided to withdraw from A.C.I.P. during the financial holdings review required of members before they can start work on the committee,' Mr. Nixon said.
'The sacrifice to serve on A.C.I.P. varies from member to member, and we appreciate Dr. Ross's willingness to go through this rigorous process,' he added.
Some experts said they were unsurprised to hear that Dr. Ross was leaving the panel.
'Given the H.H.S. interference into the A.C.I.P. process and meeting agenda, it's no surprise to me that even members of this R.F.K. hand-selected committee would not feel comfortable participating in such an orchestrated event that bypasses scientific evidence and transparency,' said Dr. Lakshmi Panagiotakopoulos, who resigned from the C.D.C. this month.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Bio-Thera Solutions and SteinCares Expand Partnership to Commercialize Biosimilars for Treatment of Inflammatory Diseases Across Latin America
Bio-Thera Solutions and SteinCares Expand Partnership to Commercialize Biosimilars for Treatment of Inflammatory Diseases Across Latin America

Yahoo

time22 minutes ago

  • Yahoo

Bio-Thera Solutions and SteinCares Expand Partnership to Commercialize Biosimilars for Treatment of Inflammatory Diseases Across Latin America

This new agreement marks the fourth product in the partnership and introduces a potential cost-effective alternative to one of the world's top-selling biologics—broadening access to specialty care for patients with chronic inflammatory diseases. The partnership further strengthens SteinCares' position as Latin America's leading one-stop-shop for biosimilars. GUANGZHOU, China and SAN JOSE, Costa Rica, June 25, 2025 /PRNewswire/ -- Bio-Thera Solutions, Ltd., a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies and biosimilars, and SteinCares, a leading specialty healthcare company in Latin America, today announced the signing of a new agreement to commercialize a proposed biosimilar of dupilumab across Latin America. This is the fourth product that the two companies agree to collaborate and strengthens their shared commitment to improving access to high-quality, cost-effective therapies in the region. Under the agreement, Bio-Thera will be responsible for product development and supply, while SteinCares will lead the registration and commercialization process throughout Latin America. "Expanding access to advanced therapies while making healthcare more affordable is central to our mission," said Mitchell Waserstein, Chief Executive Officer at SteinCares. "Through this collaboration, we are reinforcing our position as one of the region's most robust biosimilar platforms in Latin America, offering a broad portfolio and pipeline tailored to the needs of patients and health systems across the region." Dupilumab is one of the top five medicines globally in terms of annual sales value, so this biosimilar is a significant milestone in SteinCares' expansion. The new partnership will potentially support the treatment of chronic inflammatory conditions in both adults and children. "This collaboration underscores our continued trust in SteinCares as a regional partner with strong regulatory, commercial, and medical capabilities," said Dr. Shengfeng Li, CEO of Bio-Thera Solutions. "By leveraging well-established commercial network of SteinCares, we aim to accelerate the delivery of safe, high-quality and affordable therapies to patients across Latin America." With a presence in over 30 countries, SteinCares continues to act as a bridge between global pharmaceutical innovation and Latin America's healthcare systems, helping to balance budgets, expand access and improve health outcomes for patients in the region. About Bio-Thera Solutions, Ltd. Bio-Thera Solutions, Ltd., a leading innovative, global biopharmaceutical company in Guangzhou, China, is dedicated to researching and developing novel therapeutics for the treatment of cancer, autoimmune, cardiovascular, eye diseases, and other severe unmet medical needs, as well as biosimilars for existing, branded biologics to treat a range of cancer and autoimmune diseases. As a leader in next generation antibody discovery and engineering, the company has advanced multiple candidates into late-stage development, including five approved products: adalimumab, bevacizumab and bevifibatide citrate Injection in China, ustekinumab in the US, and tocilizumab and bevacizumab in the US and in EU. In addition, the company has more than 20 promising candidates in clinical trials, focusing on immuno-oncology in the post-PD-1 era and targeted therapies such as antibody-drug conjugates (ADCs). For more information, please visit or follow us on X (@bio_thera_sol) and WeChat (Bio-Thera). About SteinCares SteinCares is a leader in commercializing and distributing specialty healthcare products in Latin America, including innovative pharmaceuticals, biosimilars, plasma-derived therapies, and complex generics. With more than 40 years of healthcare experience and operations in over 30 countries in Latin America and the Caribbean, SteinCares serves as a trusted partner for global pharmaceutical companies entering the region. The company is deeply committed to creating healthcare opportunities that positively impact the lives of patients and their families, with a vision of expanding access to innovative and cost-effective treatments. Learn more at or follow us on LinkedIn. Cautionary Note Regarding Forward-Looking Statements This news release contains certain forward-looking statements relating to Bio-Thera Solutions and SteinCares. Readers are strongly cautioned that reliance on any forward-looking statements involves known and unknown risks and uncertainties. The forward-looking statements include, among others, those containing "could," "may," "should," "will," "would," "anticipate," "believe," "plan," "promising," "potentially," or similar expressions. They reflect the companies' current views with respect to future events that are based on what the companies believe are reasonable assumptions in view of information currently available to Bio-Thera Solutions and SteinCares and are not a guarantee of future performance or developments. Actual results and events may differ materially from information contained in the forward-looking statements as a result of a number of factors, including, but not limited to, risks and uncertainties inherent in pharmaceutical research and development, such as the uncertainties of pre-clinical and clinical studies. Other risks and uncertainties include challenges in obtaining regulatory approvals, manufacturing, marketing, competition, intellectual property, product efficacy or safety, changes in global healthcare situation, changes in the company's financial conditions, and changes to applicable laws and regulations, etc. Forward-looking statements contained herein are made only as of the date of their initial publication. Unless required by laws or regulations, Bio-Thera Solutions and SteinCares undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, changes in the companies' views or otherwise. Bio-Thera ContactsBio-Thera Solutions, Ltd.:Bert E. Thomas IV+1.410.627.1734bethomas@ View original content to download multimedia: SOURCE Bio-Thera Solutions, Ltd

Brighton High names distinguished grads. Who are Dennis Bowdoin and Arthur Pancioli?
Brighton High names distinguished grads. Who are Dennis Bowdoin and Arthur Pancioli?

Yahoo

time23 minutes ago

  • Yahoo

Brighton High names distinguished grads. Who are Dennis Bowdoin and Arthur Pancioli?

Brighton High School is honoring two graduates for excellence in their respective fields. BHS is inducting Dennis Bowdoin and Dr. Arthur Pancioli to the Brighton Distinguished Alumni Wall of Fame. Brighton Area Schools announced the inductions June 23. Bowdoin and Pancioli will be honored during a ceremony Oct. 16 at BHS. They'll also be part of the school's homecoming parade and celebrated during halftime at the district's homecoming football game Oct. 10. Bowdoin and Pancioli were selected by the Brighton Distinguished Alumni Wall of Fame Committee, entering four years of selections. 'We continue to be amazed as we learn of the incredible stories of Brighton alumni,' BAS Superintendent Matt Outlaw wrote in a release. 'Their success is obvious, but the impact (they're) making on others and the world around them is even more impressive.' Bowdoin graduated from BHS in 1965. He started Movieland Video, growing the business from one store to 360. Bowdoin started the Helicopter Air Specialty Service and was inducted into the Michigan Aviation Hall of Fame in 2024. Bowdoin built the Maple Grove Heliport, managed the Maple Grove and Romeo State Airports, is an FAA Safety Counselor, is a Michigan Aeronautics Consultant, and wrote and ran the helicopter program for Western Michigan University. Bowdoin has also been a planning commissioner in Livingston County, a member of the Conway Township Planning Commission, and Conway Township Constable for 22 years. Pancioli graduated from BHS in 1982. He graduated from the University of Michigan with a bachelor's degree in computer science in 1987, then from U of M Medical School in 1991. Pancioli is the chief clinical officer and senior vice president for the University of Cincinnati Health System and a professor of emergency medicine for the University of Cincinnati College of Medicine. Pancioli was previously chair for the Department of Emergency Medicine in the UC College of Medicine and chief transformation officer for the University of Cincinnati Health System. He specializes in emergency medicine and neurovascular emergencies, and served as a member of the Michigan Air National Guard from 1989-1993 as a flight surgeon before earning the rank of captain. He's also published several peer-reviewed publications. Other members of the Brighton Distinguished Alumni Wall of Fame include Drew Henson (Class of 1998), Dave LewAllen (1975), Kate Lawrence (1976), Col. Dr. Karin Flood (1988), Bruce Ritter (1971), Kari Seitz (1988) and Charles Brady (1941). 'It's such a pleasure to tell the stories of these outstanding alumni every year,' Outlaw said. 'Each story offers us a chance to celebrate as a community but also provides wonderful examples for our students of what is possible with hard work and dedication.' — Contact reporter Evan Sasiela at esasiela@ Follow him on X @SalsaEvan. This article originally appeared on Livingston Daily: Who are BHS grads Dennis Bowdoin and Arthur Pancioli?

Cremations, burials of unclaimed bodies to start this week, says NLHS
Cremations, burials of unclaimed bodies to start this week, says NLHS

Yahoo

time28 minutes ago

  • Yahoo

Cremations, burials of unclaimed bodies to start this week, says NLHS

Dozens of bodies being kept in long-term storage by Newfoundland and Labrador Health Services will soon be buried, says a health authority chief operating officer. CBC News first reported 28 bodies were being stored in freezer units outside of the Health Sciences Centre in St. John's due to a lack of space in the morgue in March, 2024. The morgue doubles as the Office of the Chief Medical Examiner. The freezers were later relocated to a hospital parking garage where a new, expanded morgue was constructed. On Monday, eastern-urban zone COO Ron Johnson announced Barrett's Funeral Home had been awarded the contract to carry out the burials. "This week we had a lot of information come through after the posting went online. So this week some cremations and burials will start and we're working our way through the process," Johnson told reporters. There are approximately 26 bodies currently in storage, Johnson said, but added the number is known to fluctuate. "I think it's a little less today, but it'll be a lot less … when the week is over," he said. CBC News asked Barrett's for an interview on Tuesday, but president Shane Mouland said he wasn't available. "Please be assured that these cremations and burials will be carried out with the utmost care, dignity, and professionalism. Our team is working closely with NLHS to ensure each individual is respectfully laid to rest in a timely manner," he said in an email. According to the amended legislation, which was filed on Dec. 24 and came into effect on Jan. 1, the health authority has the power to bury unclaimed bodies after two weeks of searching for next of kin and then five days after the person is posted on a dedicated website. In May, CBC News reported Newfoundland and Labrador Health Services hadn't buried a single body since legislation came into effect and the website wasn't public. At the time, health authority spokesperson Mikaela Etchegary said the delay was due to the need to finalize "operationalizing the legislation." On May 28, a total of 26 names were posted on the website with a deadline of June 4 for people to respond in order to claim the body. In response, several community efforts were launched to bury some of those individuals in their hometowns. Other regions dealing with increasing numbers of bodies going unclaimed have brought in public memorial ceremonies to mark their burials. In a statement to CBC News, health authority spokesperson Jon Oake said something of that nature isn't in the works at the moment. "While group ceremonies are not planned, we continue to explore meaningful ways to collectively honour unclaimed individuals. Community partnerships and consultation play a key role in shaping this important work," he wrote. In a statement dated June 3, seniors' advocate Susan Walsh said she had spoken with staff regarding how the deceased will be handled and was assured the wishes of the deceased, if known, would be carried out. She was also told NLHS will make sure the deceased are sent back to their home communities for burial, and permanent markers with the person's name will be erected at the grave site. "With the new process and timelines outlined in legislation, this unfortunate situation should be resolved going forward," wrote Walsh. Download our free CBC News app to sign up for push alerts for CBC Newfoundland and Labrador. Sign up for our daily headlines newsletter here. Click here to visit our landing page.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store